Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc. (DRUG) — Form SCHEDULE 13G/A: Ownership over 5% (passive) (amendment)

SC 13G/ADRUGFiled Aug 14, 2026, 10:02 AM ET

About this filing

Bright Minds Biosciences Inc. (DRUG) filed Form SCHEDULE 13G/A (ownership over 5% (passive) (amendment)) with the SEC on Aug 14, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.

View original filing on SEC.gov

Key facts

Document: —

More DRUG filings

6-K
SEC filing
Filed Nov 2, 2026
6-K
SEC filing
Filed Oct 2, 2026
6-K
SEC filing
Filed Sep 30, 2026
6-K
SEC filing
Filed Aug 14, 2026
S-8
SEC filing
Filed Aug 12, 2026
SC 13G/A
Ownership over 5% (passive) (amendment)
Filed Aug 12, 2026

Not investment advice. Summaries can contain errors; the SEC filing is the official record.